東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Infectious complications in biologic...

Cervera, Carlos.

Linked to FindBook

Google Book

Amazon

博客來

Infectious complications in biologic and targeted therapies

Record Type:	Electronic resources : Monograph/item
Title/Author:	Infectious complications in biologic and targeted therapies/ edited by Carlos Cervera, Jose Maria Aguado.
other author:	Cervera, Carlos.
Published:	Cham :Springer International Publishing : : 2022.,
Description:	x, 473 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	Infection - Prevention. -
Online resource:	https://doi.org/10.1007/978-3-031-11363-5
ISBN:	9783031113635

Infectious complications in biologic and targeted therapies
Infectious complications in biologic and targeted therapies[electronic resource] /edited by Carlos Cervera, Jose Maria Aguado. - Cham :Springer International Publishing :2022. - x, 473 p. :ill., digital ;24 cm.

This book aims to approach the epidemiology, diagnosis and management of infectious complications related to the use of biologic and targeted therapies. The first part is a general overview on the epidemiology and prevention of infections with the use of these agents. Timelines, pre-treatment evaluation, use of vaccines and travel counseling. In the second part, we will analyze the specific risk of infections associated with the use of the most important agents. The third part approach the problem on a syndromic point of view. For example, how to evaluate pulmonary infiltrates in a patient receiving biologic agents. This part III includes the most difficult and conflicting syndromes that clinicians may face when evaluating these patients. This book is intended not only for infectious diseases specialists, but also for different medical specialties prescribing biologic and targeted therapies.

ISBN: 9783031113635

Standard No.: 10.1007/978-3-031-11363-5doiSubjects--Topical Terms:

1961457
Infection
--Prevention.

LC Class. No.: RC111

Dewey Class. No.: 616.9

Infectious complications in biologic and targeted therapies
LDR:01862nmm a2200313 a 4500 001 2305883
003 DE-He213
005 20221118130254.0
006 m d
007 cr nn 008maaau
008 230409s2022 sz s 0 eng d
020 $a 9783031113635 $q (electronic bk.)
020 $a 9783031113628 $q (paper)
024 7 $a 10.1007/978-3-031-11363-5 $2 doi
035 $a 978-3-031-11363-5
040 $a GP $c GP
041 0 $a eng
050 4 $a RC111
072 7 $a MJ $2 bicssc
072 7 $a MED045000 $2 bisacsh
072 7 $a MJ $2 thema
082 0 4 $a 616.9 $2 23
090 $a RC111 $b .I43 2022
245 0 0 $a Infectious complications in biologic and targeted therapies $h [electronic resource] / $c edited by Carlos Cervera, Jose Maria Aguado.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a x, 473 p. : $b ill., digital ; $c 24 cm.
520 $a This book aims to approach the epidemiology, diagnosis and management of infectious complications related to the use of biologic and targeted therapies. The first part is a general overview on the epidemiology and prevention of infections with the use of these agents. Timelines, pre-treatment evaluation, use of vaccines and travel counseling. In the second part, we will analyze the specific risk of infections associated with the use of the most important agents. The third part approach the problem on a syndromic point of view. For example, how to evaluate pulmonary infiltrates in a patient receiving biologic agents. This part III includes the most difficult and conflicting syndromes that clinicians may face when evaluating these patients. This book is intended not only for infectious diseases specialists, but also for different medical specialties prescribing biologic and targeted therapies.
650 0 $a Infection $x Prevention. $3 1961457
650 0 $a Infection $x Treatment. $3 802809
650 0 $a Therapeutics $x Complications. $3 2163087
650 0 $a Drug targeting. $3 768297
700 1 $a Cervera, Carlos. $3 3609385
700 1 $a Aguado, Jose Maria. $3 3609386
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-031-11363-5
950 $a Medicine (SpringerNature-11650)